Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis (Q40726564)

23 September 2017

title

Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis (English)

1 reference

23 September 2017

Louise A Scrocchi

1 reference

23 September 2017

Yan Chen

1 reference

23 September 2017

Stefko Waschuk

1 reference

23 September 2017

Feng Wang

1 reference

23 September 2017

Sindy Cheung

1 reference

23 September 2017

Audrey A Darabie

1 reference

23 September 2017

JoAnne McLaurin

1 reference

23 September 2017

Paul E Fraser

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Journal of Molecular Biology

23 September 2017

published in

1 reference

23 September 2017

volume

318

1 reference

23 September 2017

1 reference

23 September 2017

page(s)

697-706

1 reference

On the Relation of Chronic Interstitial Pancreatitis to the Islands of Langerhans and to Diabetes Melutus

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Amyloid and polypeptide hormones: What is their interrelationship?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Islet amyloid polypeptide (IAPP;Amylin) influences the endocrine but not the exocrine rat pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Effects of sequential proline substitutions on amyloid formation by human amylin20-29.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Controlling amyloid beta-peptide fibril formation with protease-stable ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

The protofilament substructure of amyloid fibrils11Edited by F. E. Cohen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Different sensitivity to the cytotoxic action of IAPP fibrils in two insulin-producing cell lines, HIT-T15 and RINm5F cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

B Cell Granule Peptides Affect Human Islet Amyloid Polypeptide (IAPP) Fibril Formationin Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

The relation of islet amyloid to the clinical type of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Longitudinal studies on the development of diabetes in individual Macaca nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

A feline model of experimentally induced islet amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Amyloid Fibril Formation from Full-Length and Fragments of Amylin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet beta-cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900164-X

10.1016/S0022-2836(02)00164-X

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference